{"id":"W3204399641","doi":"10.1016/j.annonc.2021.08.338","title":"59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; Biliary tract cancer; Cisplatin; Oncology; Internal medicine; Biliary tract; Phases of clinical research; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001490271,0.001168296,0.002435998,0.0004368586,0.0004883526,0.001221667,0.001270518,0.001378013,0.01064433],"category_scores_gemma":[0.001100015,0.0006990829,0.002228081,0.0005495423,0.0008333839,0.0009429407,0.0005391838,0.004278308,0.001798968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00107974,"about_ca_system_score_gemma":0.002096145,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002739056,"about_ca_topic_score_gemma":0.008916392,"domain_scores_codex":[0.9994615,0.0003012691,0.00002914123,0.00007706184,0.00003709363,0.00009394282],"domain_scores_gemma":[0.9990587,0.000163076,0.0001404683,0.00008333232,0.00005085683,0.0005036622],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9003859,0.035301,0.002493039,0.0006461602,0.001614922,0.00006875395,0.0001061158,0.001180715,0.009455518,0.0002805845,0.00269658,0.04577068],"study_design_scores_gemma":[0.7008981,0.2882506,0.005828194,0.00003878271,0.0007899844,0.0000727033,0.00005262244,0.0005797289,0.0011975,0.0001382054,0.002128559,0.00002513812],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9841965,0.002656579,0.0005837205,0.0007917313,0.00047155,0.003544021,0.003003833,0.0001320267,0.00462006],"genre_scores_gemma":[0.9693092,0.004974357,0.003273005,0.001882857,0.0003832931,0.003689654,0.006298815,0.0001007701,0.01008802],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01064433,"threshold_uncertainty_score":0.03560877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07922289748400511,"score_gpt":0.4031511512382979,"score_spread":0.3239282537542928,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}